Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.
Use of erythropoiesis-stimulating agents in the treatment of myelosuppresive chemotherapy-induced anemia has been shown to increase hemoglobin levels and reduce the need for transfusions in patients with cancer.
Naeim
Arash
A
University of California Los Angeles, Los Angeles; McKesson Specialty Care Solutions, San Rafael; ICON Clinical Research, Lifecycle Sciences Group, San Francisco; and Amgen, Thousand Oaks, CA.
Friedman
Lyssa
L
Whitlock
Kimberly B
KB
Pasta
David J
DJ
Elkin
Eric P
EP
Lubeck
Deborah P
DP
Viswanathan
Hema N
HN
Glaspy
John
J